Condition

Advanced Lung Non-Small Cell Carcinoma clinical trials and research

• 10Clinical trials
• 1Country

Newest Advanced Lung Non-Small Cell Carcinoma clinical trials

All recruiting trials (10)

• Understand cancer cachexia subtypes in advanced cancers

  This study tests how cancer cachexia presents in people with advanced colorectal, pancreatic, or lung cancer to see if different subtypes relate to outcomes.

  Recruiting Kaiser Permanente · Pleasanton, California · NCT07776353

• Morning versus afternoon immunotherapy for advanced or metastatic solid tumors

  This trial tests whether giving standard immune checkpoint inhibitor therapy in the morning versus the afternoon changes outcomes for adults with advanced or metastatic solid tumors.

  Recruiting Phase 4 OHSU Knight Cancer Institute · Portland, Oregon · NCT07405086

• SX-682 with Atezolizumab for advanced or metastatic NSCLC

  This phase 2 trial tests whether combining SX-682 with atezolizumab can help people with advanced, metastatic, or recurrent NSCLC who have progressed after prior treatments.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07322341

• GT103 plus pembrolizumab for advanced STK11‑mutant non‑small cell lung cancer

  This trial tests whether adding GT103 to pembrolizumab can help adults with advanced or metastatic STK11‑mutant non‑small cell lung cancer.

  Recruiting Phase 2 Roswell Park Cancer Institute · Buffalo, New York · NCT07017829

• Adding diclofenac to single-agent immunotherapy for metastatic non-small cell lung cancer

  This trial tests if adding the NSAID diclofenac to single‑agent PD‑1/PD‑L1 immunotherapy can help people with metastatic non‑small cell lung cancer who are showing early signs of progression.

  Recruiting at 2 sites Phase 2 Emory University · Atlanta, Georgia and 1 other locations · NCT06731270

• Combining carfilzomib and sotorasib for treating advanced lung cancer with KRAS G12C mutation

  This study is testing a new combination of two drugs, carfilzomib and sotorasib, to see if it can safely help people with advanced lung cancer that has a specific KRAS G12C mutation after they have tried other treatments.

  Recruiting at 2 sites Phase 1 City of Hope Medical Center · Duarte, California and 1 other locations · NCT06249282

• Combining chemotherapy with immunotherapy for older adults with advanced lung cancer

  This study is testing if adding chemotherapy to immunotherapy can help older adults with advanced lung cancer live longer and feel better compared to just using immunotherapy alone.

  Recruiting at 271 sites Phase 3 National Cancer Institute (NCI) · Fayetteville, Arkansas and 329 other locations · NCT06096844

• Observational study on cancer cachexia subtypes

  This study is trying to identify different types of weight and muscle loss in patients with advanced colorectal, lung, or pancreatic cancers to help improve future treatments.

  Recruiting at 196 sites University of Rochester · Fort Smith, Arkansas and 224 other locations · NCT06073431

• Combining MRX-2843 and Osimertinib for Advanced Lung Cancer Treatment

  This study is testing whether combining two medications, MRX-2843 and osimertinib, can safely help people with advanced lung cancer caused by EGFR mutations.

  Recruiting Phase 1 Emory University · Atlanta, Georgia · NCT04762199

• Using osimertinib to treat lung cancer with specific genetic mutations

  This study is testing if a medication called osimertinib can help people with advanced lung cancer that has a specific genetic mutation feel better and live longer.

  Recruiting at 215 sites Phase 2 National Cancer Institute (NCI) · Anchorage, Alaska and 346 other locations · NCT03191149

Related topics

Quick answers

How many Advanced Lung Non-Small Cell Carcinoma clinical trials are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →